NuCryo Vascular, Inc.

NuCryo Vascular, Inc. is a medical device company based in Sunnyvale, California. Founded in 2014, the company specializes in the manufacturing and commercialization of the PolarCath Balloon Dilatation System, a cryoplasty device designed to treat peripheral arterial disease (PAD). After acquiring the PolarCath technology, which was initially developed by interventional cardiologist James Joye and received FDA clearance in 2002, NuCryo Vascular enhanced its production capabilities. The PolarCath system combines balloon angioplasty with controlled cooling technology, offering benefits such as uniform vessel dilation, reduced trauma to the vessel wall, and prevention of restenosis. The company provides manufacturing, sales, marketing, and customer support for the PolarCath system and has partnered with Lokai Medical for distribution in the United States. NuCryo Vascular primarily serves healthcare providers, including hospitals and vascular specialists, focusing on improving treatment outcomes for patients with PAD.

• Employees 2
• Founded 2014